Phathom Pharmaceuticals reported revenue of $74.27M and net income of -$17.58M for the quarter ended Jun 2026, up 88.0% year over year. This income statement covers 32 quarters of results from Sep 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||||||||||||||||
| Revenue | 0.68M | 1.91M | 7.32M | 16.35M | 29.66M | 28.52M | 39.50M | 49.50M | 57.58M | 58.30M | 74.27M | |||||||||||||||||||||
| Cost of RevenueCost of Rev | 0.17M | 0.43M | 1.38M | 2.36M | 3.81M | 3.72M | 5.04M | 6.19M | 7.65M | 12.00M | 15.10M | |||||||||||||||||||||
| Gross Profit | 0.52M | 1.49M | 5.95M | 14.00M | 25.85M | 24.80M | 34.47M | 43.31M | 49.94M | 46.30M | 59.18M | |||||||||||||||||||||
| Operating items | ||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 16.61M | 13.55M | 17.66M | 18.82M | 19.02M | 15.95M | 11.48M | 12.76M | 12.26M | 13.39M | 9.43M | 7.38M | 8.69M | 8.58M | 9.18M | 9.08M | 7.03M | 7.49M | 7.77M | 7.81M | ||||||||||||
| Selling, General & AdministrativeSG&A | 16.53M | 19.49M | 20.25M | 26.55M | 23.51M | 30.70M | 18.60M | 18.94M | 23.40M | 57.00M | 62.01M | 75.87M | 76.10M | 76.68M | 94.47M | 85.31M | 51.56M | 48.37M | 54.01M | 55.33M | ||||||||||||
| Other Operating ExpensesOther Opex | ||||||||||||||||||||||||||||||||
| Operating ExpensesOpex | 33.14M | 33.04M | 37.91M | 45.36M | 42.53M | 46.64M | 30.08M | 31.70M | 35.66M | 70.39M | 71.44M | 83.25M | 84.79M | 85.27M | 103.66M | 94.39M | 58.59M | 55.86M | 61.78M | 63.14M | ||||||||||||
| Operating IncomeOp. Inc | -33.14M | -33.04M | -37.91M | -45.36M | -42.53M | -46.64M | -30.08M | -31.70M | -35.66M | -69.88M | -69.95M | -77.30M | -70.80M | -59.42M | -78.86M | -59.92M | -15.27M | -5.93M | -15.48M | -3.96M | ||||||||||||
| EBIT | -33.14M | -33.04M | -37.91M | -45.36M | -42.53M | -46.64M | -30.08M | -31.70M | -35.66M | -69.88M | -69.95M | -77.30M | -70.80M | -59.42M | -78.86M | -59.92M | -15.27M | -5.93M | -15.48M | -3.96M | ||||||||||||
| Non-operating items | ||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 1.49M | 2.77M | 2.76M | 5.67M | 9.28M | 9.60M | 9.22M | 9.62M | 10.11M | 13.03M | 17.17M | 17.76M | 18.48M | 18.59M | 18.07M | 17.52M | 16.11M | 16.42M | 15.80M | 15.10M | ||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.01M | 0.01M | 0.01M | 0.11M | 0.73M | 1.29M | 1.46M | 0.35M | 2.72M | 3.35M | 4.31M | 3.62M | 3.71M | 3.51M | 2.64M | 1.79M | 1.41M | 1.20M | 1.74M | 1.51M | ||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | -2.05M | -0.02M | -0.01M | -0.00M | -0.01M | -0.09M | 0.02M | 0.00M | -0.20M | -0.01M | -0.04M | -0.01M | -0.01M | 0.05M | -0.02M | -0.15M | -0.01M | -0.01M | -0.83M | -0.02M | ||||||||||||
| Non Operating IncomeNon Op. Inc. | -3.52M | -2.79M | -2.76M | -5.56M | -8.56M | -8.40M | -7.74M | -9.26M | -7.58M | -9.70M | -12.90M | -14.15M | -14.78M | -15.03M | -15.45M | -15.89M | -14.70M | -15.22M | -14.89M | -13.62M | ||||||||||||
| Net income details | ||||||||||||||||||||||||||||||||
| EBT | -34.61M | -35.81M | -40.66M | -50.92M | -51.08M | -54.96M | -37.83M | -40.97M | -43.05M | -79.56M | -82.81M | -91.44M | -85.57M | -74.50M | -94.29M | -75.66M | -29.97M | -21.14M | -29.54M | -17.56M | ||||||||||||
| Profit After TaxPAT | -36.66M | -35.83M | -40.66M | -50.92M | -51.09M | -55.05M | -37.81M | -40.97M | -43.24M | -79.57M | -82.85M | -91.45M | -85.58M | -74.45M | -94.32M | -75.81M | -29.97M | -21.15M | -30.37M | -17.58M | ||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -34.61M | -35.81M | -40.66M | -50.92M | -51.08M | -54.96M | -37.83M | -40.97M | -43.05M | -79.56M | -82.81M | -91.44M | -85.57M | -74.50M | -94.29M | -75.66M | -29.97M | -21.14M | -29.54M | -17.56M | ||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -34.61M | -35.81M | -40.66M | -50.92M | -51.08M | -54.96M | -37.83M | -40.97M | -43.05M | -79.56M | -82.81M | -91.44M | -85.57M | -74.50M | -94.29M | -75.66M | -29.97M | -21.14M | -29.54M | -17.56M | ||||||||||||
| Income towards Parent CompanyParent Net Inc | -34.61M | -35.81M | -40.66M | -50.92M | -51.08M | -54.96M | -37.83M | -40.97M | -43.05M | -79.56M | -82.81M | -91.44M | -85.57M | -74.50M | -94.29M | -75.66M | -29.97M | -21.14M | -29.54M | -17.56M | ||||||||||||
| Net Income towards Common StockholdersNet Income | -34.61M | -35.81M | -40.66M | -50.92M | -51.08M | -54.96M | -37.83M | -40.97M | -43.05M | -79.56M | -82.81M | -91.44M | -85.57M | -74.50M | -94.29M | -75.66M | -29.97M | -21.14M | -29.54M | -17.56M | ||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||
| EPS (Basic) | -0.93 | -0.97 | -1.07 | -1.33 | -1.32 | -1.40 | -0.89 | -0.84 | -0.76 | -1.55 | -1.42 | -1.56 | -1.32 | -1.18 | -1.31 | -1.04 | -0.41 | -0.29 | -0.36 | -0.21 | ||||||||||||
| EPS (Diluted) | -0.93 | -0.97 | -1.07 | -1.33 | -1.32 | -1.40 | -0.89 | -0.84 | -0.76 | -1.55 | -1.42 | -1.56 | -1.32 | -1.18 | -1.31 | -1.04 | -0.41 | -0.29 | -0.36 | -0.21 | ||||||||||||
| Shares Outstanding | 37.30M | 37.00M | 38.04M | 38.27M | 38.82M | 39.12M | 42.35M | 48.50M | 56.78M | 51.29M | 58.37M | 58.56M | 64.63M | 63.18M | 71.97M | 72.47M | 73.40M | 72.92M | 82.05M | 83.75M | ||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 37.30M | 37.00M | 38.04M | 38.27M | 38.82M | 39.12M | 42.35M | 48.50M | 56.78M | 51.29M | 58.37M | 58.56M | 64.63M | 63.18M | 71.97M | 72.47M | 73.40M | 72.92M | 82.05M | 83.75M | ||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 30.05M | 30.51M | 38.15M | 38.37M | 41.14M | 41.47M | 43.57M | 56.64M | 56.81M | 57.97M | 58.52M | 58.60M | 68.32M | 68.52M | 69.64M | 70.10M | 71.04M | 71.42M | 79.44M | 80.07M | ||||||||||||
| EBITDA | -33.14M | -33.04M | -37.91M | -45.36M | -42.53M | -46.64M | -30.08M | -31.70M | -35.66M | -69.88M | -69.95M | -77.30M | -70.80M | -59.42M | -78.86M | -59.92M | -15.27M | -5.93M | -15.48M | -3.96M | ||||||||||||
| Interest ExpensesInt Expense | 1.49M | 2.77M | 2.76M | 5.67M | 9.28M | 9.60M | 9.22M | 9.62M | 10.11M | 13.03M | 17.17M | 17.76M | 18.48M | 18.59M | 18.07M | 17.52M | 16.11M | 16.42M | 15.80M | 15.10M |